Literature DB >> 9648498

WHO meeting on maternal and neonatal pneumococcal immunization.

.   

Abstract

Entities:  

Keywords:  Age Factors; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; Family And Household; Family Characteristics; Family Relationships; Health; Health Services; Immunization; Infant; Infections; International Agencies; Mothers; Organizations; Parents; Population; Population Characteristics; Primary Health Care; Respiratory Infections--prevention and control; Un; Who; Youth

Mesh：

Year:  1998        PMID： 9648498

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  9 in total

1.  Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.

Authors:  R Malley; M Lipsitch; A Stack; R Saladino; G Fleisher; S Pelton; C Thompson; D Briles; P Anderson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children.

Authors:  Julie Rowe; Stephanie T Yerkovich; Peter Richmond; Devinda Suriyaarachchi; Elizabeth Fisher; Leonie Feddema; Richard Loh; Peter D Sly; Patrick G Holt
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Intranasal immunization with a colloid-formulated bacterial extract induces an acute inflammatory response in the lungs and elicits specific immune responses.

Authors:  A Rial; D Lens; L Betancor; H Benkiel; J S Silva; J A Chabalgoity
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

4.  Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice.

Authors:  D M Ferreira; M Darrieux; D A Silva; L C C Leite; J M C Ferreira; P L Ho; E N Miyaji; M L S Oliveira
Journal:  Clin Vaccine Immunol       Date:  2009-03-11

5.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.

Authors:  Richard Malley; Philipp Henneke; Sarah C Morse; Michael J Cieslewicz; Marc Lipsitch; Claudette M Thompson; Evelyn Kurt-Jones; James C Paton; Michael R Wessels; Douglas T Golenbock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-04       Impact factor: 11.205

Review 6.  Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development.

Authors:  Richard Malley
Journal:  J Mol Med (Berl)       Date:  2010-01-05       Impact factor: 4.599

7.  Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue.

Authors:  Jeffrey Pido-Lopez; William W Kwok; Timothy J Mitchell; Robert S Heyderman; Neil A Williams
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

8.  Safety and immunogenicity of neonatal pneumococcal conjugate vaccination in Papua New Guinean children: a randomised controlled trial.

Authors:  William S Pomat; Anita H J van den Biggelaar; Suparat Phuanukoonnon; Jacinta Francis; Peter Jacoby; Peter M Siba; Michael P Alpers; John C Reeder; Patrick G Holt; Peter C Richmond; Deborah Lehmann
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

9.  Development of a model of focal pneumococcal pneumonia in young rats.

Authors:  Richard Malley; Anne M Stack; Robert N Husson; Claudette M Thompson; Gary R Fleisher; Richard A Saladino
Journal:  J Immune Based Ther Vaccines       Date:  2004-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.